Piper Jaffray Upgrades Bausch & Lomb

Analyst Steven Harmill says the eye healthcare product company's Purevision spherical lens is running greater than 150% of its plan since relaunching in April

Piper Jaffray upgrades eye healthcare product company Bausch & Lomb (BOL ) to outperform from market perform.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.